Table 2.
Frequency of fentanyl administration among patients with moderate and severe pain
| ICD-10 chapters | Total | Moderatea, b | Fentanyl adm. | Severea, c | Fentanyl adm. | |
|---|---|---|---|---|---|---|
| n | % | n (%) | % | n (%) | ||
| I | Infectious and parasitic diseases | 244 | 73.0 (66.9–78.4) | 8 (3.3) | 27.0 (21.6–33.1) | 21 (8.6) |
| II | In situ neoplasms | 96 | 63.0 (52.0–72.2) | 3 (3.1) | 37.0 (27.8–48.0) | 10 (10.4) |
| III | Diseases of blood, blood-forming organs and certain disorders involving the immune mechanism | 40 | 57.5 (40.9–73.0) | 1 (2.5) | 42.5 (27.0–59.1) | 11 (27.5) |
| IV | Endocrine, nutritional, and metabolic disease | 77 | 70.1 (58.6–80.0) | 2 (2.6) | 29.9 (20.0–41.3) | 5 (6.5) |
| V | Mental and behavioral disorders | 80 | 83.8 (73.8–91.1) | – | 16.2 (8.9–26.2) | 3 (3.8) |
| VI | Diseases of the nervous system | 157 | 63.7 (55.7–71.2) | 3 (1.9) | 36.3 (28.8–44.3) | 7 (4.5) |
| VII | Diseases of the eye and adnexa | 5 | 80.0 (28.4–99.5) | – | 20.0 (0.5–71.6) | – |
| VIII | Diseases of the ear and mastoid process | 14 | 64.3 (35.1–87.2) | – | 35.7 (12.8–64.9) | 2 (14.3) |
| IX | Diseases of the circulatory system | 1064 | 68.2 (65.3–71.0) | 111 (10.4) | 31.8 (29.0–34.7) | 156 (14.7) |
| X | Diseases of the respiratory system | 491 | 75.5 (70.4–78.3) | 16 (3.2) | 24.5 (21.7–29.6) | 48 (9.8) |
| XI | Diseases of the digestive system | 814 | 50.5 (47.0–54.0) | 39 (4.8) | 49.5 (46.0–53.0) | 167 (20.5) |
| XII | Diseases of skin and subcutaneous tissue | 12 | 83.3 (51.6–97.9) | – | 16.7 (2.1–48.4) | – |
| XIII | Diseases of the musculoskeletal system and connective tissue | 468 | 45.5 (40.9–50.1) | 38 (8.1) | 54.5 (49.9–59.1) | 145 (31.0) |
| XIV | Diseases of the genitourinary system | 370 | 53.0 (47.7–58.2) | 25 (6.8) | 47.0 (41.8–52.3) | 90 (24.3) |
| XV | Pregnancy, childbirth, and the puerperium | 114 | 59.6 (50.1–68.7) | 3 (2.6) | 40.4 (31.3–49.9) | 9 (7.9) |
| XVI | Certain conditions originating in the perinatal period | 0 | – | – | – | – |
| XVII | Congenital malformations, deformations, and chromosomal abnormalities | 3 | – | – | – | – |
| XVIII | Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified | 2022 | 63.1 (61.0–65.2) | 82 (4.1) | 36.9 (34.8–39.0) | 240 (11.9) |
| XIX | Injury, poisoning, and certain other consequences of external causes | 3442 | 59.6 (58.0–61.3) | 336 (10.0) | 40.4 (38.7–42.0) | 994 (28.9) |
| XX | External causes of morbidity and mortality | 0 | – | – | – | – |
| XXI | Factors influencing health status and contact with health services | 1630 | 69.8 (67.5–72.0) | 118 (7.2) | 30.2 (28.0–32.5) | 182 (11.2) |
| – | Unknown | 287 | 85.0 (80.4–88.9) | 2 (0.7) | 15.0 (11.1–19.6) | 8 (2.9) |
| Total | 11,430 | 27.7 (27.3–28.2) | 788 (6.9) | 32.2 (31.7–32.6) | 2098 (18.4) |
Abbreviations: ICD-10 10th version of the international classification of diseases, Adm administration
aGiven as proportions (%) with 95% confidence intervals
bModerate pain defined as a numeric rating scale 4–6 or moderate pain registered on a 4-point verbal rating scale upon initial patient triage
cSevere pain defined as a numeric rating scale ≥ 7 or severe pain registered on a 4-point verbal rating scale upon initial patient triage